Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: per strandberg who wrote (3274)	12/10/1997 5:10:00 PM
From: Andreas Helke	Read Replies (2) of 6136

I have the impression that there is almost no connection between market caps and the true value of a biotech company. If I think that the market cap of a company is too high I'll stay away. If it looks like it is too low and I don't find a good reason for the low valuation I start buying. This way I ended up with big positions in Ligand and Agouron. If my analysis is correct then in a few years I'll end up with big gains. If it turns out to be flawed then I should probably move most of my money into index funds. In the last two years index funds have outperformed my portfolio. But I am still optimistic that I will outperform the indices in the next few years. I think my portfolio has a chance to go up 15 to 30% a year when the general market just follows earnings growth of 5 to 15%. But if we get a bear market I won't have much luck with my current stocks. Andreas

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next